Vector-mediated drug delivery to the brain.

Area of Science:

• Neuroscience
• Pharmacology
• Biomedical Engineering

Background:

• The aging global population is associated with increased prevalence of neurodegenerative diseases, brain cancers, and infections.
• The blood-brain barrier (BBB) significantly restricts the entry of potential therapeutic agents into the central nervous system (CNS).
• The BBB's impermeability is due to tight junctions in brain capillary endothelial cells and low endocytic activity, preventing passage of polar and lipid-insoluble substances.

Purpose of the Study:

• To review strategies for enhancing drug delivery across the blood-brain barrier (BBB).
• To highlight the challenges in developing safe and effective CNS drug delivery systems.
• To emphasize vector-mediated strategies for overcoming BBB limitations.

Main Methods:

• Literature review of existing and emerging drug delivery strategies for the CNS.
• Focus on vector-mediated approaches for enhanced drug transport across the BBB.
• Analysis of the mechanisms and efficacy of different delivery systems.

Main Results:

• The BBB poses a major obstacle for CNS drug development.
• Various strategies are being explored to facilitate therapeutic molecule passage across the BBB.
• Vector-mediated strategies show promise for targeted and efficient drug delivery.

Conclusions:

• Overcoming the BBB is critical for treating CNS disorders.
• Developing effective drug delivery systems is an ongoing challenge.
• Vector-mediated strategies represent a key area of research for improving CNS therapeutics.